Variant report
Variant | esv3351385 |
---|---|
Chromosome Location | chr9:3038702-3041100 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs372119940 | chr9:3038707-3038708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs144939652 | chr9:3038724-3038725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs186503232 | chr9:3038725-3038726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs539378467 | chr9:3038876-3038877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10124397 | chr9:3038913-3038914 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs572149009 | chr9:3038924-3038925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs190214043 | chr9:3038927-3038928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs560902105 | chr9:3038940-3038941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs138818265 | chr9:3038958-3038959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs372532327 | chr9:3038965-3038966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs28394220 | chr9:3038979-3038980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs200519847 | chr9:3038991-3038992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs13290269 | chr9:3038992-3038993 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs58705941 | chr9:3039000-3039001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs374390402 | chr9:3039019-3039020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs372962565 | chr9:3039034-3039035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs10969616 | chr9:3039036-3039037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs201215357 | chr9:3039044-3039045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs202075669 | chr9:3039045-3039046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs200641245 | chr9:3039046-3039047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201644009 | chr9:3039047-3039048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs199741091 | chr9:3039050-3039051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs61066992 | chr9:3039051-3039052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541851097 | chr9:3039068-3039069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563755394 | chr9:3039070-3039071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs143199842 | chr9:3039071-3039072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs552631104 | chr9:3039092-3039093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs560084332 | chr9:3039122-3039123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181760573 | chr9:3039130-3039131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs548215430 | chr9:3039147-3039148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs186112627 | chr9:3039152-3039153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536768663 | chr9:3039165-3039166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs550627653 | chr9:3039193-3039194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs190877921 | chr9:3039216-3039217 | Enhancers ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
35 | rs183448857 | chr9:3039259-3039260 | Enhancers ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
36 | rs62533959 | chr9:3039299-3039300 | Enhancers ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
37 | rs552898181 | chr9:3039312-3039313 | Enhancers ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
38 | rs572805768 | chr9:3039332-3039333 | Enhancers ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
39 | rs535324792 | chr9:3039336-3039337 | Enhancers ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
40 | rs200477409 | chr9:3039346-3039347 | Enhancers ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
41 | rs112102722 | chr9:3039348-3039349 | Enhancers ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
42 | rs368308490 | chr9:3039349-3039350 | Enhancers ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
43 | rs71329454 | chr9:3039375-3039376 | Enhancers ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
44 | rs71507994 | chr9:3039376-3039377 | Enhancers ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
45 | rs78344646 | chr9:3039384-3039385 | Enhancers ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
46 | rs138702769 | chr9:3039409-3039410 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs199517702 | chr9:3039410-3039411 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs372018437 | chr9:3039411-3039412 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs10969617 | chr9:3039412-3039413 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs140578064 | chr9:3039414-3039415 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 16715143 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 21373258 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Autism | 20808228 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:3031200-3039200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr9:3032800-3042200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr9:3039200-3039400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr9:3039200-3039400 | Flanking Bivalent TSS/Enh | Breast Myoepithelial Primary Cells | Breast |
5 | chr9:3039200-3039600 | ZNF genes & repeats | H9 Cell Line | embryonic stem cell |
6 | chr9:3039200-3039600 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr9:3039400-3039600 | Bivalent/Poised TSS | Breast Myoepithelial Primary Cells | Breast |
8 | chr9:3039600-3040400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr9:3040200-3040600 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
10 | chr9:3040200-3041600 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr9:3040400-3041400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
12 | chr9:3040600-3043000 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |